Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - Pharmaceutical News - Bernstein Liebhard LLP Evaluating Potential Valsartan Lawsuits for Cancer and Liver Injuries Allegedly Caused by Contaminated Heart and Blood Pressure Medications - March 23, 2019

Pharmacy News Article

 1/11/19 - Bernstein Liebhard LLP Evaluating Potential Valsartan Lawsuits for Cancer and Liver Injuries Allegedly Caused by Contaminated Heart and Blood Pressure Medications

NEW YORK, Jan. 11, 2019 /PRNewswire/ Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, has launched a new investigation into recent recalls for valsartan and other angiotensin II receptor blockers that may have been contaminated with cancer-causing chemicals.

Bernstein Liebhard LLP.  (PRNewsFoto/Bernstein Liebhard LLP) (PRNewsfoto/Bernstein Liebhard LLP)

"Since June of 2018, dangerous impurities have been detected in active ingredients used to manufacture generic heart failure and high blood pressure drugs, including valsartan, irbesartan, and losartan," saidSandy A. Liebhard, a partner at Bernstein Liebhard LLP."Our attorneys are committed to ensuring that the victims of these contaminated medications are fairly and fully compensated for all of their injury-related damages."

The firm is now offering free, no-obligation legal reviews to patients who were diagnosed with certain cancers or serious liver injuries after ingesting recalled valsartan, irbesartan, or losartan products.

What Patients Should Know About Recalls Involving Valsartan and other ARBs

According to the U.S. Food & Drug Administration (FDA), tests have detected trace amounts of N-Nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine(NDEA) in the Active Pharmaceutical Ingredient (API) used to manufacture valsartan and other generic ARBs.

NDMA and NDEA are considered probable human carcinogens. Exposure to these chemicals may also cause liver damage.

Since June 2018, generic drug makers in the United States and more than 20 other countries have been forced to recall ARB medications, including:

  • Valsartan
  • Valsartan in combination with Amlodipine
  • Valsartan in combination with Hydrochlorothiazide (Valsartan HCT)
  • Valsartan in combination with Amlodipine and Hydrochlorothiazide
  • Losartan
  • Irbesartan

The API used in the recalled medications was supplied by India-based Hetero Labs and Zhejiang Huahai Pharmaceuticals of China. According to the FDA, the chemicals are likely a byproduct of a production method utilized by these manufacturers since 2014.

Patients taking these ARBs should check with their pharmacist to determine if their medication was recalled. The FDA also maintains updated lists of valsartan products under recall, losartan medications under recall, and irbesartan products under recallat its website.

Patients with a recalled ARB should not stop taking their medication before they have obtained a replacement, as doing so could lead to serious adverse health consequences.

Learn More About Filing a Valsartan Lawsuit

Patients, or their surviving family members, may be entitled to compensation if they ingested a recalled valsartan, losartan, or irbesartan medication AFTER 2014 and were diagnosed with one of the following injuries:

  • Liver Cancer
  • Liver Injury with at least 3 Days Hospitalization
  • Cancer of the intestines
  • Rectal Cancer
  • Colon Cancer
  • Duodenal Cancer
  • Small intestine cancer
  • Stomach Cancer
  • Kidney Cancer
  • Bowel cancer

To learn if you qualify to file a valsartan lawsuit,please contact Bernstein Liebhard LLP by visiting the Firm's website, or by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is aNew York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than$3.5 billionon behalf of our clients. Bernstein Liebhard LLP has been named to The National Law Journal's"Plaintiffs' Hot List" 13 times and listed inThe Legal 500for 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York10016

ATTORNEY ADVERTISING. 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street,New York, New York10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Cision View original content to download multimedia:

SOURCE Bernstein Liebhard LLP

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Mar 24: A Look Inside the Top 200 Drugs
Mar 25: Medication Use During Pregnancy & Lactation
Mar 26: Nutrigenomics - Nutritional Influences on the Genome
Mar 27: ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Mar 28: Alternatives and Complements to Prescription Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement